SS Innovations Launches Innovative Robotic Cardiac Surgery Program in India

Dr. Sudhir Srivastava, a world-leading cardiac surgeon, performed the world’s first beating heart robotic cardiac bypass surgery using the SSi Mantra Surgical Robotic System

FORT LAUDERDALE, FL, Oct. 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces the launch of an innovative robotic cardiac surgery program in India utilizing its flagship SSi Mantra surgical robotic system.

The company’s cardiac program aims to revive and invigorate the field of robotic coronary artery bypass and intracardiac surgery in India, and to train surgeons throughout the country in these procedures using the SSi Mantra. More than 20 robotic cardiac surgeries have been successfully performed using SS Innovations’ surgical robotic system in India, to date.

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, said, “Each year more than 2,000,000 open heart surgeries are performed globally, however in India, doctors perform approximately 100,000 surgeries annually. Additionally, today more than 95% of patients are still being operated on in a maximally invasive approach globally, which means the splitting of the sternum is required to gain access to the heart. This results in greater blood loss, increased risk of wound infection with longer recoveries for the patient. 

“While in the USA, I helped develop many ‘World’s First’ cardiac bypass procedures that avoided such invasive approaches. Most of my cardiac bypass patients went home in just 3 days or less. The results were outstanding. It is high time that we utilize technology to its fullest potential.  It was always my goal to revive robotic cardiac surgery and while developing the Mantra Surgical Robotic System, I was acutely aware of how our platform would always include cardiac surgery as a viable treatment option for many patients globally.  Every patient should have access to gold standard surgical care, and we believe that our cost-effective surgical robotic system is a key part of the solution.